224 related articles for article (PubMed ID: 28648521)
1. Ratiometric co-delivery of multiple chemodrugs in a single nanocarrier.
Chen C; Tao R; Ding D; Kong D; Fan A; Wang Z; Zhao Y
Eur J Pharm Sci; 2017 Sep; 107():16-23. PubMed ID: 28648521
[TBL] [Abstract][Full Text] [Related]
2. On-demand combinational delivery of curcumin and doxorubicin via a pH-labile micellar nanocarrier.
Li H; Li M; Chen C; Fan A; Kong D; Wang Z; Zhao Y
Int J Pharm; 2015 Nov; 495(1):572-578. PubMed ID: 26387617
[TBL] [Abstract][Full Text] [Related]
3. Co-assembly of doxorubicin and curcumin targeted micelles for synergistic delivery and improving anti-tumor efficacy.
Ma W; Guo Q; Li Y; Wang X; Wang J; Tu P
Eur J Pharm Biopharm; 2017 Mar; 112():209-223. PubMed ID: 27913127
[TBL] [Abstract][Full Text] [Related]
4. The effective combination therapy against human osteosarcoma: doxorubicin plus curcumin co-encapsulated lipid-coated polymeric nanoparticulate drug delivery system.
Wang L; Wang W; Rui Z; Zhou D
Drug Deliv; 2016 Nov; 23(9):3200-3208. PubMed ID: 26987435
[TBL] [Abstract][Full Text] [Related]
5. Comb-like amphiphilic copolymers bearing acetal-functionalized backbones with the ability of acid-triggered hydrophobic-to-hydrophilic transition as effective nanocarriers for intracellular release of curcumin.
Zhao J; Wang H; Liu J; Deng L; Liu J; Dong A; Zhang J
Biomacromolecules; 2013 Nov; 14(11):3973-84. PubMed ID: 24107101
[TBL] [Abstract][Full Text] [Related]
6. Co-delivery of Doxorubicin and Curcumin with Polypeptide Nanocarrier for Synergistic Lymphoma Therapy.
Guo W; Song Y; Song W; Liu Y; Liu Z; Zhang D; Tang Z; Bai O
Sci Rep; 2020 May; 10(1):7832. PubMed ID: 32398729
[TBL] [Abstract][Full Text] [Related]
7. Synergistically Improved Anti-tumor Efficacy by Co-delivery Doxorubicin and Curcumin Polymeric Micelles.
Wang J; Ma W; Tu P
Macromol Biosci; 2015 Sep; 15(9):1252-61. PubMed ID: 25981672
[TBL] [Abstract][Full Text] [Related]
8. Ratiometric delivery of two therapeutic candidates with inherently dissimilar physicochemical property through pH-sensitive core-shell nanoparticles targeting the heterogeneous tumor cells of glioma.
Xu HL; Fan ZL; ZhuGe DL; Tong MQ; Shen BX; Lin MT; Zhu QY; Jin BH; Sohawon Y; Yao Q; Zhao YZ
Drug Deliv; 2018 Nov; 25(1):1302-1318. PubMed ID: 29869524
[TBL] [Abstract][Full Text] [Related]
9. Mixed poly(vinyl pyrrolidone)-based drug-loaded nanomicelles shows enhanced efficacy against pancreatic cancer cell lines.
Veeren A; Bhaw-Luximon A; Mukhopadhyay D; Jhurry D
Eur J Pharm Sci; 2017 May; 102():250-260. PubMed ID: 28323118
[TBL] [Abstract][Full Text] [Related]
10. Comparison of hyaluronic acid-based micelles and polyethylene glycol-based micelles on reversal of multidrug resistance and enhanced anticancer efficacy in vitro and in vivo.
Wang J; Li Y; Wang L; Wang X; Tu P
Drug Deliv; 2018 Nov; 25(1):330-340. PubMed ID: 29350064
[TBL] [Abstract][Full Text] [Related]
11. Programmable co-delivery of the immune checkpoint inhibitor NLG919 and chemotherapeutic doxorubicin via a redox-responsive immunostimulatory polymeric prodrug carrier.
Sun JJ; Chen YC; Huang YX; Zhao WC; Liu YH; Venkataramanan R; Lu BF; Li S
Acta Pharmacol Sin; 2017 Jun; 38(6):823-834. PubMed ID: 28504251
[TBL] [Abstract][Full Text] [Related]
12. Tumor-targeted micelle-forming block copolymers for overcoming of multidrug resistance.
Braunová A; Kostka L; Sivák L; Cuchalová L; Hvězdová Z; Laga R; Filippov S; Černoch P; Pechar M; Janoušková O; Šírová M; Etrych T
J Control Release; 2017 Jan; 245():41-51. PubMed ID: 27871991
[TBL] [Abstract][Full Text] [Related]
13. Self-assembled oligopeptide nanostructures for co-delivery of drug and gene with synergistic therapeutic effect.
Wiradharma N; Tong YW; Yang YY
Biomaterials; 2009 Jun; 30(17):3100-9. PubMed ID: 19342093
[TBL] [Abstract][Full Text] [Related]
14. Anti-cancer activity of anti-GLUT1 antibody-targeted polymeric micelles co-loaded with curcumin and doxorubicin.
Abouzeid AH; Patel NR; Rachman IM; Senn S; Torchilin VP
J Drug Target; 2013 Dec; 21(10):994-1000. PubMed ID: 24098980
[TBL] [Abstract][Full Text] [Related]
15. Nanomicelles loaded with doxorubicin and curcumin for alleviating multidrug resistance in lung cancer.
Gu Y; Li J; Li Y; Song L; Li D; Peng L; Wan Y; Hua S
Int J Nanomedicine; 2016; 11():5757-5770. PubMed ID: 27843316
[TBL] [Abstract][Full Text] [Related]
16. GSH/pH dual-responsive biodegradable camptothecin polymeric prodrugs combined with doxorubicin for synergistic anticancer efficiency.
Li J; Hu ZE; Yang XL; Wu WX; Xing X; Gu B; Liu YH; Wang N; Yu XQ
Biomater Sci; 2019 Aug; 7(8):3277-3286. PubMed ID: 31180396
[TBL] [Abstract][Full Text] [Related]
17. Zwitterionic Polymer Micelles with Dual Conjugation of Doxorubicin and Curcumin: Synergistically Enhanced Efficacy against Multidrug-Resistant Tumor Cells.
Zhao G; Sun Y; Dong X
Langmuir; 2020 Mar; 36(9):2383-2395. PubMed ID: 32036662
[TBL] [Abstract][Full Text] [Related]
18. Dual-drug delivery of curcumin and platinum drugs in polymeric micelles enhances the synergistic effects: a double act for the treatment of multidrug-resistant cancer.
Scarano W; de Souza P; Stenzel MH
Biomater Sci; 2015 Jan; 3(1):163-74. PubMed ID: 26214199
[TBL] [Abstract][Full Text] [Related]
19. Micelles of d-α-Tocopheryl Polyethylene Glycol 2000 Succinate (TPGS 2K) for Doxorubicin Delivery with Reversal of Multidrug Resistance.
Hao T; Chen D; Liu K; Qi Y; Tian Y; Sun P; Liu Y; Li Z
ACS Appl Mater Interfaces; 2015 Aug; 7(32):18064-75. PubMed ID: 26214761
[TBL] [Abstract][Full Text] [Related]
20. Biodegradable polymer-curcumin conjugate micelles enhance the loading and delivery of low-potency curcumin.
Yang R; Zhang S; Kong D; Gao X; Zhao Y; Wang Z
Pharm Res; 2012 Dec; 29(12):3512-25. PubMed ID: 22961588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
